SlideShare a Scribd company logo
1 of 41
Curriculum Vitae ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
DEMAM BERDARAH DENGUE Diagnosa dan Penatalaksanaan KURNIA F. JAMIL Sub-Bagian Penyakit Tropik & Infeksi Bagian Ilmu Penyakit Dalam  FK-UNSYIAH/RSUZA BANDA ACEH 2012
Demam Berdarah  Dengue Masih merupakan masalah penyakit infeksi yang serius  di  Indonesia DEPKES-RI tahun 2005 Jumlah kasus 80.837 dengan 1.099 kematian Ledakan kasus 5 tahunan Sejak tahun 1968 dan seterusnya Self Limiting Diseases
Pendahuluan ,[object Object],[object Object],[object Object],[object Object]
Overview of the Major Viral Hemorrhagic Fever   Family  Genus  Mortality  Transmission Cook GC, Zumla A. Manson’s Tropical Diseases, 2003 Arenaviridae  Lassa  West Africa  16%  Rodents Junin’58*  Argentina  30%  Rodents Machupo’63  Bolivia  25%  Rodents  Sabia’90  Brazil  30%  Rodents Guanarito’90  Venezuela  25%  Rodents Flaviviridae  Dengue 1-4  0.2-2%  Mosquitos Yellow fever virus *  10-85%  Mosquitos Kyasanur *  India  5%  Ticks Omsk  Rusia  2%  Ticks Bunyaviridae  Phlebovirus- Rift Valley HF  1%  Mosquitos  Hantavirus - HF Renal Synd *  5-15%  Rodents Nairovirus- Crimean Congo HF  20-50%  Ticks Puumala  1%  Rodents Filoviridae  Marburg **  20-25%  Monkey Ebola  **  70-90%  Monkey  Alphaviridae  Chikungunya #  0%  Mosquitos Reoviridae  Coltvirus  <1%  Ticks  *  Cardiac complication ** Nosocomial  # Mild HF
Replication and Transmission of Dengue Virus (Part 1) 1. Virus transmitted to human in mosquito saliva 2. Virus replicates in target organs 3. Virus infects white blood cells and lymphatic tissues 4. Virus released and circulates in blood 3 4 1 2
Patogenesis DBD ,[object Object],[object Object]
Viral Risk Factors for DHF Pathogenesis ,[object Object],[object Object],[object Object],[object Object]
Hypothesis on Pathogenesis of DHF (Part 1) ,[object Object]
Neutralizing antibody to Dengue 1 virus  Dengue 1 virus  Homologous Antibodies Form Non-infectious Complexes Non-neutralizing antibody Complex formed by neutralizing antibody and virus 1 1 1 1 1
Hypothesis on Pathogenesis of DHF (Part 2) ,[object Object]
Non-neutralizing antibody to Dengue 1 virus  Dengue 2 virus  Heterologous Antibodies Form Infectious Complexes Complex formed by non-neutralizing antibody and virus 2 2 2 2 2 2
Hypothesis on Pathogenesis of DHF (Part 3) ,[object Object]
Heterologous Complexes Enter More Monocytes, Where Virus Replicates Non-neutralizing antibody Dengue 2 virus  Complex formed by non-neutralizing antibody and Dengue 2 virus 2 2 2 2 2 2 2 2 2 2 2 2
Hypothesis on Pathogenesis of DHF (Part 4) ,[object Object]
Kompleks Imun
 
Manifestations of dengue infection Dengue virus infection Asymptomatic Symptomatic Undifferentiated fever Dengue fever syndrome Without haemorrhage With unusual haemorrhage Dengue haemorrhagic fever No shock Dengue shock syndrome Dengue fever Dengue haemorrhagic fever
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The following classifications are proposed : • Probable- an acute febrile illness with two or more of  the following manifestations : –  headache –  retro-orbital pain –  myalgia –  arthralgia –  rash –  haemorrhagic manifestations –  leukopenia –  serology (+) or DF occurrence at the same location /  time
Kriteria Diagnosis DBD (WHO 1997) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],۵ ۵ ۵ ۵ Hematokrit meningkat > 20% dibandingkan hematokrit rata-rata pada usia, jenis kelamin, dan populasi yang sama Hematokrit turun hingga > 20% dari hematokrit awal, setelah pemberian cairan Terdapat efusi pleura, asites , hiponatremia, hipoalbuminemia
Diagnosa Banding ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pola panas Demam Dengue Ruam primer Ruam sekunder I VI V VII VIII III II IV 36  o C 39  o C 40  o C 38  o C 37  o C
 
 
Warning Signs for Dengue Shock ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Four Grades of DHF ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Problem in Dengue Fever/Dengue Hemorrhagic Fever in Indonesia ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Incidence of Dengue Hemorrhagic Fever in Indonesia 1968-1996 Ministry of Health, Rep of Indonesia
Mortality of Dengue Hemorrhagic Fever in Indonesia 1968-1997 Ministry of Health, Rep of Indonesia
Pemeriksaan Penunjang ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment of Dengue Haemorrhagic Fever ,[object Object],[object Object],[object Object],[object Object]
Suspek   DBD   (kriteria WHO  1997 ) Hb, Ht, Trombo N Hb, Ht normal Trombo < 100.00 0 Hb, Ht normal Trombo > 100.000 < 150.000  Hb, Ht meningkat Trombo  normal  atau turun Observasi Rawat jalan Periksa Hb, Ht  Leko Tr/24 jam  Rawat Rawat Observasi dan pemberian cairan suspek DBD dewasa tanpa renjatan di IGD Observasi Rawat jalan Periksa Hb Ht Leko Tr /24 jam
Suspek  DBD Perdarahan Spontan  dan  Masif (-) Syok (-) -  Hb,Ht (n) -  Tromb. <100.000 -  Infus Kristaloid * -   Hb,Ht,Tromb. tiap 24 jam Hb,Ht  meningkat > 20%  Tromb.<100.000 Pemberian cairan pada suspek DBD dewasa di ruang rawat -  Hb,Ht  meningkat 10-20% -  Tromb. <100.000 -  Infus Kristaloid* -   Hb,Ht,Tromb. tiap  12  jam ** Protokol pemberian  Cairan DBD dengan Ht  Meningkat  >  20% *  Volume cairan kristaloid per hari yang diperlukan: Sesuai rumus berikut  1500 + 20 x (berat badan dalam kg - 20) Contoh volume rumatan untuk berat badan 55 kg :  1500 + 20 x (55-20) = 2200 ml (Pan American Health Organization:  Dengue and DengueHemorrhagic Fever: Guidelines for Prevention and Control . PAHO: Washington, D.C., 1994: 67). **  Pemantauan disesuaikan dengan fase/hari  perjalanan penyakit dan kondisi klinis
Penatalaksanaan  DBD dengan peningkatan Ht > 20% (1) 5% defisit cairan Terapi awal cairan intravena Kristaloid 6-7 ml/kg/jam PERBAIKAN Hematokrit dan frekuensi nadi turun,  tekanan  darah stabil,  produksi urin meningkat TIDAK MEMBAIK Hematokrit, nadi meningkat Tekanan nadi menurun < 20 mm Hg Produksi urin menurun Kurangi infus kristaloid 5 ml/kg/jam TANDA VITAL DAN HEMATOKRIT MEMBURUK Infus kristaloid 10 ml/kg/jam PERBAIKAN PERBAIKAN  TIDAK MEMBAIK  Kurangi infus kristaloid 3 ml/kg/jam Infus kristaloid  15 ml/kg/jam PERBAIKAN  KONDISI TIDAK STABIL Tanda renjatan Terapi cairan dihentikan 24 – 48 jam Tatalaksana sesuai  Protokol Renjatan dan perdarahan PERBAIKAN  Evaluasi 3-4 jam
Terapi cairan DBD dengan peningkatan Ht > 20% (2) Volume cairan per hari : Defisit cairan + kebutuhan cairan harian Defisit 5% berat badan  = 5% x berat badan Kebutuhan cairan harian = 1500 + 20x (berat badan-20) Evaluasi tanda vital tiap jam Hematokrit tiap 4 jam Jumlah cairan disesuaikan dengan perbaikan klinis lihat protokol Contoh untuk berat badan 60 kg: Defisit 5% berat badan = 5%x60x1000ml = 3000 ml Kebutuhan harian  = 1500+ 20 x 40  = 2300 ml Jumlah cairan = 5300/24 jam
KASUS DBD Perdarahan Spontan Masif (-) Syok (-) Hb,Ht (n)/ meningkat Tromb.>100-150.000 -RL 4 jam/kolf -Hb,Ht,Tromb. tiap 24 jam Hb,Ht (n)/ meningkat Tromb.<100.000 -RL 4 jam/kolf -Hb,Ht,Tromb. tiap 12 jam Hb,Ht,Tromb. (n) 24 jam stabil Hb,Ht  meningkat Tromb.>100-150.000 -RL 4 jam/kolf -H,Ht,Tromb. 1 x 24 jam Klinis memburuk : TD  turun ,  Nadi meningkat , Diuresis  berkurang P rotokol DBD dengan syok Hb,Ht (n)/ meningkat Tromb.<100.000 -RL 4 jam/kolf - Hb,Ht,Tromb. 1x12 jam Pulang 24 jam Hb,Ht, Tromb.(n) Hemodinamik baik 24 jam stabil Pulang Catatan pulang : - Pasien tidak demam, hemodinamik baik - Bila keadaan pasien memburuk segera ke IGD - Kontrol poliklinik 2 x 24 jam kemudian (DPL)   Penatalaksanaan Suspek DBD dewasa (tanpa syok dan perdarahan) di ruang rawat
Penatalaksanaan Perdarahan pada DBD dewasa KASUS DBD : Perdarahan S PONTAN dan MASIF  : -Epistaksis tidak terkendali   -Hematemesis melena/hematoskezia -Perdarahan otak Syok (-) -DPL,hemostase KID  (+) -Transfusi komponen darah : *   PRC (Hb<10g   * FFP *   T C  (Tromb.<100.000 - Heparinisasi *Hb,Ht,Tromb. tiap 4-6 jam *Ulang hemostase 24 jam kemudian KID (-) -Transfusi komponen darah : *PRC (Hb<10g% ) *FFP *T C  (Tromb.<100.000) *Hb,Ht, Tromb. tiap 4-6 jam *Ulang hemostase 24 jam kemudian
Penatalaksanaan Sindrom Renjatan Dengue
Kriteria Pemulangan pasien DBD ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
KESIMPULAN ,[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

Perdarahan Saluran Cerna
Perdarahan Saluran CernaPerdarahan Saluran Cerna
Perdarahan Saluran CernaDika Saja
 
St elevasi miokard infark
St elevasi miokard infarkSt elevasi miokard infark
St elevasi miokard infarkDwi Handayani
 
Management of Acute Coronary Syndrome - Non STEMI
Management of Acute Coronary Syndrome - Non STEMIManagement of Acute Coronary Syndrome - Non STEMI
Management of Acute Coronary Syndrome - Non STEMIIsman Firdaus
 
EKG, Hipertrofi Jantung
EKG, Hipertrofi JantungEKG, Hipertrofi Jantung
EKG, Hipertrofi JantungADam Raeyoo
 
Case Report diare Akut Dehidrasi Ringan Sedang ppt
Case Report diare Akut Dehidrasi Ringan Sedang pptCase Report diare Akut Dehidrasi Ringan Sedang ppt
Case Report diare Akut Dehidrasi Ringan Sedang pptSyscha Lumempouw
 
2018 New Update Guidelines of Acute Coronary Syndrome, Indonesian Heart Assoc...
2018 New Update Guidelines of Acute Coronary Syndrome, Indonesian Heart Assoc...2018 New Update Guidelines of Acute Coronary Syndrome, Indonesian Heart Assoc...
2018 New Update Guidelines of Acute Coronary Syndrome, Indonesian Heart Assoc...Isman Firdaus
 
Patofisiologi hipertensi
Patofisiologi hipertensiPatofisiologi hipertensi
Patofisiologi hipertensiSofiaNofianti
 
Morning Report Neurology
Morning Report NeurologyMorning Report Neurology
Morning Report NeurologyPhil Adit R
 
Bagan MTBS
Bagan MTBSBagan MTBS
Bagan MTBSmoharip1
 
Tatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral
Tatalaksana Klinis Infeksi HIV dan Terapi AntiretroviralTatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral
Tatalaksana Klinis Infeksi HIV dan Terapi AntiretroviralSurya Amal
 

What's hot (20)

Perdarahan Saluran Cerna
Perdarahan Saluran CernaPerdarahan Saluran Cerna
Perdarahan Saluran Cerna
 
Demam reumatik
Demam reumatikDemam reumatik
Demam reumatik
 
Demam tifoid anak
Demam tifoid anakDemam tifoid anak
Demam tifoid anak
 
Demam tifoid
Demam tifoidDemam tifoid
Demam tifoid
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
St elevasi miokard infark
St elevasi miokard infarkSt elevasi miokard infark
St elevasi miokard infark
 
Lepra
LepraLepra
Lepra
 
Management of Acute Coronary Syndrome - Non STEMI
Management of Acute Coronary Syndrome - Non STEMIManagement of Acute Coronary Syndrome - Non STEMI
Management of Acute Coronary Syndrome - Non STEMI
 
Keseimbangan cairan & elektrolit
Keseimbangan cairan & elektrolitKeseimbangan cairan & elektrolit
Keseimbangan cairan & elektrolit
 
EKG, Hipertrofi Jantung
EKG, Hipertrofi JantungEKG, Hipertrofi Jantung
EKG, Hipertrofi Jantung
 
demam tifoid amee
demam tifoid ameedemam tifoid amee
demam tifoid amee
 
Case Report diare Akut Dehidrasi Ringan Sedang ppt
Case Report diare Akut Dehidrasi Ringan Sedang pptCase Report diare Akut Dehidrasi Ringan Sedang ppt
Case Report diare Akut Dehidrasi Ringan Sedang ppt
 
Sepsis
SepsisSepsis
Sepsis
 
2018 New Update Guidelines of Acute Coronary Syndrome, Indonesian Heart Assoc...
2018 New Update Guidelines of Acute Coronary Syndrome, Indonesian Heart Assoc...2018 New Update Guidelines of Acute Coronary Syndrome, Indonesian Heart Assoc...
2018 New Update Guidelines of Acute Coronary Syndrome, Indonesian Heart Assoc...
 
Patofisiologi hipertensi
Patofisiologi hipertensiPatofisiologi hipertensi
Patofisiologi hipertensi
 
Morning Report Neurology
Morning Report NeurologyMorning Report Neurology
Morning Report Neurology
 
Bagan MTBS
Bagan MTBSBagan MTBS
Bagan MTBS
 
Stilah untuk suara nafas
Stilah untuk suara nafasStilah untuk suara nafas
Stilah untuk suara nafas
 
Tamponade Jantung
Tamponade JantungTamponade Jantung
Tamponade Jantung
 
Tatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral
Tatalaksana Klinis Infeksi HIV dan Terapi AntiretroviralTatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral
Tatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral
 

Viewers also liked

Viewers also liked (19)

Askep dhf
Askep dhfAskep dhf
Askep dhf
 
Demam berdarah dengue (dbd)
Demam berdarah dengue (dbd)Demam berdarah dengue (dbd)
Demam berdarah dengue (dbd)
 
Demam Berdarah Dengue
Demam Berdarah DengueDemam Berdarah Dengue
Demam Berdarah Dengue
 
Asuhan keperawatan pada kasus dhf
Asuhan keperawatan pada kasus dhfAsuhan keperawatan pada kasus dhf
Asuhan keperawatan pada kasus dhf
 
Preskas dhf
Preskas dhfPreskas dhf
Preskas dhf
 
DHF
DHFDHF
DHF
 
appendisitis
appendisitisappendisitis
appendisitis
 
Ppt dhf
Ppt dhfPpt dhf
Ppt dhf
 
Laporan kasus
Laporan kasusLaporan kasus
Laporan kasus
 
DHF pada Anak
DHF pada AnakDHF pada Anak
DHF pada Anak
 
pathway dhfPathway dhf
pathway dhfPathway dhfpathway dhfPathway dhf
pathway dhfPathway dhf
 
Laporan kasus
Laporan kasusLaporan kasus
Laporan kasus
 
Demam berdarah-dengue-dbd
Demam berdarah-dengue-dbdDemam berdarah-dengue-dbd
Demam berdarah-dengue-dbd
 
Apendisitis akut & kronik
Apendisitis akut & kronikApendisitis akut & kronik
Apendisitis akut & kronik
 
Ppt apendisitis ppt
Ppt apendisitis pptPpt apendisitis ppt
Ppt apendisitis ppt
 
Penyuluhan tentang bagaimana pencegah dbd
Penyuluhan tentang bagaimana pencegah dbdPenyuluhan tentang bagaimana pencegah dbd
Penyuluhan tentang bagaimana pencegah dbd
 
Penyuluhan dbd
Penyuluhan dbdPenyuluhan dbd
Penyuluhan dbd
 
Ppt DBD
Ppt DBDPpt DBD
Ppt DBD
 
Penanggulangan Penyakit Demam Berdarah
Penanggulangan Penyakit Demam BerdarahPenanggulangan Penyakit Demam Berdarah
Penanggulangan Penyakit Demam Berdarah
 

Similar to DEMAM BERDARAH DENGUE Diagnosa dan Penatalaksanaan

Similar to DEMAM BERDARAH DENGUE Diagnosa dan Penatalaksanaan (20)

Dengue Fever(2),09
Dengue Fever(2),09Dengue Fever(2),09
Dengue Fever(2),09
 
Dengue & It's Management in Bangladesh
Dengue & It's Management in BangladeshDengue & It's Management in Bangladesh
Dengue & It's Management in Bangladesh
 
Dr Deepak Dadhich DENGUE FEVER ppt under guidance of Dr Jitendra Verma Sir Pr...
Dr Deepak Dadhich DENGUE FEVER ppt under guidance of Dr Jitendra Verma Sir Pr...Dr Deepak Dadhich DENGUE FEVER ppt under guidance of Dr Jitendra Verma Sir Pr...
Dr Deepak Dadhich DENGUE FEVER ppt under guidance of Dr Jitendra Verma Sir Pr...
 
9.dengue seminar
9.dengue seminar9.dengue seminar
9.dengue seminar
 
DENGUE_FEVER_&_DHF.ppt
DENGUE_FEVER_&_DHF.pptDENGUE_FEVER_&_DHF.ppt
DENGUE_FEVER_&_DHF.ppt
 
DENGUE_FEVER_&_DHF.ppt
DENGUE_FEVER_&_DHF.pptDENGUE_FEVER_&_DHF.ppt
DENGUE_FEVER_&_DHF.ppt
 
DENGUE_FEVER_&_DHF_1.ppt
DENGUE_FEVER_&_DHF_1.pptDENGUE_FEVER_&_DHF_1.ppt
DENGUE_FEVER_&_DHF_1.ppt
 
DENGUE_FEVER_&_DHF.ppt
DENGUE_FEVER_&_DHF.pptDENGUE_FEVER_&_DHF.ppt
DENGUE_FEVER_&_DHF.ppt
 
Dengue, dengue hemorrhagic fever, dengue shock syndrome
Dengue, dengue hemorrhagic fever, dengue shock syndromeDengue, dengue hemorrhagic fever, dengue shock syndrome
Dengue, dengue hemorrhagic fever, dengue shock syndrome
 
Dengue
DengueDengue
Dengue
 
Dengue fever
Dengue feverDengue fever
Dengue fever
 
Dengue fever
Dengue fever Dengue fever
Dengue fever
 
Dengue diagnosis, treatment, prevention and control
Dengue diagnosis, treatment, prevention and controlDengue diagnosis, treatment, prevention and control
Dengue diagnosis, treatment, prevention and control
 
Dengue
DengueDengue
Dengue
 
Dengue
DengueDengue
Dengue
 
dengue diagnosis and management
dengue diagnosis and managementdengue diagnosis and management
dengue diagnosis and management
 
Dengue Cu Resident 01 2010
Dengue Cu Resident 01 2010Dengue Cu Resident 01 2010
Dengue Cu Resident 01 2010
 
The dengue syndrome_Vighnesh D
The dengue syndrome_Vighnesh DThe dengue syndrome_Vighnesh D
The dengue syndrome_Vighnesh D
 
Infectious Disease
Infectious DiseaseInfectious Disease
Infectious Disease
 
Dengue in children (F) - Copy.ppt
Dengue in children (F) - Copy.pptDengue in children (F) - Copy.ppt
Dengue in children (F) - Copy.ppt
 

More from Mulkan Fadhli

Tajul Muluk pada sistem pertanian
Tajul Muluk pada sistem pertanianTajul Muluk pada sistem pertanian
Tajul Muluk pada sistem pertanianMulkan Fadhli
 
Pengumuman Pemenang RG FK Unsyiah 2012
Pengumuman Pemenang RG FK Unsyiah 2012Pengumuman Pemenang RG FK Unsyiah 2012
Pengumuman Pemenang RG FK Unsyiah 2012Mulkan Fadhli
 
Pengumuman Pemenangan RG
Pengumuman Pemenangan RGPengumuman Pemenangan RG
Pengumuman Pemenangan RGMulkan Fadhli
 
Pengumumanan Pemenangan TG
Pengumumanan Pemenangan TGPengumumanan Pemenangan TG
Pengumumanan Pemenangan TGMulkan Fadhli
 
Radioterapi of lung cancer
Radioterapi of lung cancerRadioterapi of lung cancer
Radioterapi of lung cancerMulkan Fadhli
 
Proses menua dan implikasinya
Proses menua dan implikasinyaProses menua dan implikasinya
Proses menua dan implikasinyaMulkan Fadhli
 
Pre ecclampsia in nefrology
Pre ecclampsia in nefrologyPre ecclampsia in nefrology
Pre ecclampsia in nefrologyMulkan Fadhli
 
Contrast nephropathy
Contrast nephropathyContrast nephropathy
Contrast nephropathyMulkan Fadhli
 
Management hiperkalemia
Management hiperkalemiaManagement hiperkalemia
Management hiperkalemiaMulkan Fadhli
 
Acei sebagai reno protektor
Acei sebagai reno protektorAcei sebagai reno protektor
Acei sebagai reno protektorMulkan Fadhli
 
Pelatihan pcr 1 eijkman
Pelatihan pcr 1 eijkmanPelatihan pcr 1 eijkman
Pelatihan pcr 1 eijkmanMulkan Fadhli
 
Enterobius vermicularis
Enterobius vermicularisEnterobius vermicularis
Enterobius vermicularisMulkan Fadhli
 
Ascaris lumbricoides
Ascaris lumbricoidesAscaris lumbricoides
Ascaris lumbricoidesMulkan Fadhli
 

More from Mulkan Fadhli (20)

Tajul Muluk pada sistem pertanian
Tajul Muluk pada sistem pertanianTajul Muluk pada sistem pertanian
Tajul Muluk pada sistem pertanian
 
Pengumuman Pemenang RG FK Unsyiah 2012
Pengumuman Pemenang RG FK Unsyiah 2012Pengumuman Pemenang RG FK Unsyiah 2012
Pengumuman Pemenang RG FK Unsyiah 2012
 
Pengumuman TG
Pengumuman TGPengumuman TG
Pengumuman TG
 
Pengumuman Pemenangan RG
Pengumuman Pemenangan RGPengumuman Pemenangan RG
Pengumuman Pemenangan RG
 
Pengumumanan Pemenangan TG
Pengumumanan Pemenangan TGPengumumanan Pemenangan TG
Pengumumanan Pemenangan TG
 
Pad slide
Pad slidePad slide
Pad slide
 
Radioterapi of lung cancer
Radioterapi of lung cancerRadioterapi of lung cancer
Radioterapi of lung cancer
 
Lung cancer, 3rd ed
Lung cancer, 3rd edLung cancer, 3rd ed
Lung cancer, 3rd ed
 
Proses menua dan implikasinya
Proses menua dan implikasinyaProses menua dan implikasinya
Proses menua dan implikasinya
 
Pre ecclampsia in nefrology
Pre ecclampsia in nefrologyPre ecclampsia in nefrology
Pre ecclampsia in nefrology
 
Isk komplikasi
Isk komplikasiIsk komplikasi
Isk komplikasi
 
Contrast nephropathy
Contrast nephropathyContrast nephropathy
Contrast nephropathy
 
Management hiperkalemia
Management hiperkalemiaManagement hiperkalemia
Management hiperkalemia
 
Acei sebagai reno protektor
Acei sebagai reno protektorAcei sebagai reno protektor
Acei sebagai reno protektor
 
Pelatihan pcr 1 eijkman
Pelatihan pcr 1 eijkmanPelatihan pcr 1 eijkman
Pelatihan pcr 1 eijkman
 
Modulasi digital
Modulasi digitalModulasi digital
Modulasi digital
 
Imunoparasitologi
ImunoparasitologiImunoparasitologi
Imunoparasitologi
 
Filariasis limfatik
Filariasis limfatikFilariasis limfatik
Filariasis limfatik
 
Enterobius vermicularis
Enterobius vermicularisEnterobius vermicularis
Enterobius vermicularis
 
Ascaris lumbricoides
Ascaris lumbricoidesAscaris lumbricoides
Ascaris lumbricoides
 

Recently uploaded

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfSanaAli374401
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.MateoGardella
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...KokoStevan
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 

Recently uploaded (20)

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 

DEMAM BERDARAH DENGUE Diagnosa dan Penatalaksanaan

  • 1.
  • 2. DEMAM BERDARAH DENGUE Diagnosa dan Penatalaksanaan KURNIA F. JAMIL Sub-Bagian Penyakit Tropik & Infeksi Bagian Ilmu Penyakit Dalam FK-UNSYIAH/RSUZA BANDA ACEH 2012
  • 3. Demam Berdarah Dengue Masih merupakan masalah penyakit infeksi yang serius di Indonesia DEPKES-RI tahun 2005 Jumlah kasus 80.837 dengan 1.099 kematian Ledakan kasus 5 tahunan Sejak tahun 1968 dan seterusnya Self Limiting Diseases
  • 4.
  • 5. Overview of the Major Viral Hemorrhagic Fever Family Genus Mortality Transmission Cook GC, Zumla A. Manson’s Tropical Diseases, 2003 Arenaviridae Lassa West Africa 16% Rodents Junin’58* Argentina 30% Rodents Machupo’63 Bolivia 25% Rodents Sabia’90 Brazil 30% Rodents Guanarito’90 Venezuela 25% Rodents Flaviviridae Dengue 1-4 0.2-2% Mosquitos Yellow fever virus * 10-85% Mosquitos Kyasanur * India 5% Ticks Omsk Rusia 2% Ticks Bunyaviridae Phlebovirus- Rift Valley HF 1% Mosquitos Hantavirus - HF Renal Synd * 5-15% Rodents Nairovirus- Crimean Congo HF 20-50% Ticks Puumala 1% Rodents Filoviridae Marburg ** 20-25% Monkey Ebola ** 70-90% Monkey Alphaviridae Chikungunya # 0% Mosquitos Reoviridae Coltvirus <1% Ticks * Cardiac complication ** Nosocomial # Mild HF
  • 6. Replication and Transmission of Dengue Virus (Part 1) 1. Virus transmitted to human in mosquito saliva 2. Virus replicates in target organs 3. Virus infects white blood cells and lymphatic tissues 4. Virus released and circulates in blood 3 4 1 2
  • 7.
  • 8.
  • 9.
  • 10. Neutralizing antibody to Dengue 1 virus Dengue 1 virus Homologous Antibodies Form Non-infectious Complexes Non-neutralizing antibody Complex formed by neutralizing antibody and virus 1 1 1 1 1
  • 11.
  • 12. Non-neutralizing antibody to Dengue 1 virus Dengue 2 virus Heterologous Antibodies Form Infectious Complexes Complex formed by non-neutralizing antibody and virus 2 2 2 2 2 2
  • 13.
  • 14. Heterologous Complexes Enter More Monocytes, Where Virus Replicates Non-neutralizing antibody Dengue 2 virus Complex formed by non-neutralizing antibody and Dengue 2 virus 2 2 2 2 2 2 2 2 2 2 2 2
  • 15.
  • 17.  
  • 18. Manifestations of dengue infection Dengue virus infection Asymptomatic Symptomatic Undifferentiated fever Dengue fever syndrome Without haemorrhage With unusual haemorrhage Dengue haemorrhagic fever No shock Dengue shock syndrome Dengue fever Dengue haemorrhagic fever
  • 19.
  • 20. The following classifications are proposed : • Probable- an acute febrile illness with two or more of the following manifestations : – headache – retro-orbital pain – myalgia – arthralgia – rash – haemorrhagic manifestations – leukopenia – serology (+) or DF occurrence at the same location / time
  • 21.
  • 22.
  • 23. Pola panas Demam Dengue Ruam primer Ruam sekunder I VI V VII VIII III II IV 36 o C 39 o C 40 o C 38 o C 37 o C
  • 24.  
  • 25.  
  • 26.
  • 27.
  • 28.
  • 29. Incidence of Dengue Hemorrhagic Fever in Indonesia 1968-1996 Ministry of Health, Rep of Indonesia
  • 30. Mortality of Dengue Hemorrhagic Fever in Indonesia 1968-1997 Ministry of Health, Rep of Indonesia
  • 31.
  • 32.
  • 33. Suspek DBD (kriteria WHO 1997 ) Hb, Ht, Trombo N Hb, Ht normal Trombo < 100.00 0 Hb, Ht normal Trombo > 100.000 < 150.000 Hb, Ht meningkat Trombo normal atau turun Observasi Rawat jalan Periksa Hb, Ht Leko Tr/24 jam Rawat Rawat Observasi dan pemberian cairan suspek DBD dewasa tanpa renjatan di IGD Observasi Rawat jalan Periksa Hb Ht Leko Tr /24 jam
  • 34. Suspek DBD Perdarahan Spontan dan Masif (-) Syok (-) - Hb,Ht (n) - Tromb. <100.000 - Infus Kristaloid * - Hb,Ht,Tromb. tiap 24 jam Hb,Ht meningkat > 20% Tromb.<100.000 Pemberian cairan pada suspek DBD dewasa di ruang rawat - Hb,Ht meningkat 10-20% - Tromb. <100.000 - Infus Kristaloid* - Hb,Ht,Tromb. tiap 12 jam ** Protokol pemberian Cairan DBD dengan Ht Meningkat > 20% * Volume cairan kristaloid per hari yang diperlukan: Sesuai rumus berikut 1500 + 20 x (berat badan dalam kg - 20) Contoh volume rumatan untuk berat badan 55 kg : 1500 + 20 x (55-20) = 2200 ml (Pan American Health Organization: Dengue and DengueHemorrhagic Fever: Guidelines for Prevention and Control . PAHO: Washington, D.C., 1994: 67). ** Pemantauan disesuaikan dengan fase/hari perjalanan penyakit dan kondisi klinis
  • 35. Penatalaksanaan DBD dengan peningkatan Ht > 20% (1) 5% defisit cairan Terapi awal cairan intravena Kristaloid 6-7 ml/kg/jam PERBAIKAN Hematokrit dan frekuensi nadi turun, tekanan darah stabil, produksi urin meningkat TIDAK MEMBAIK Hematokrit, nadi meningkat Tekanan nadi menurun < 20 mm Hg Produksi urin menurun Kurangi infus kristaloid 5 ml/kg/jam TANDA VITAL DAN HEMATOKRIT MEMBURUK Infus kristaloid 10 ml/kg/jam PERBAIKAN PERBAIKAN TIDAK MEMBAIK Kurangi infus kristaloid 3 ml/kg/jam Infus kristaloid 15 ml/kg/jam PERBAIKAN KONDISI TIDAK STABIL Tanda renjatan Terapi cairan dihentikan 24 – 48 jam Tatalaksana sesuai Protokol Renjatan dan perdarahan PERBAIKAN Evaluasi 3-4 jam
  • 36. Terapi cairan DBD dengan peningkatan Ht > 20% (2) Volume cairan per hari : Defisit cairan + kebutuhan cairan harian Defisit 5% berat badan = 5% x berat badan Kebutuhan cairan harian = 1500 + 20x (berat badan-20) Evaluasi tanda vital tiap jam Hematokrit tiap 4 jam Jumlah cairan disesuaikan dengan perbaikan klinis lihat protokol Contoh untuk berat badan 60 kg: Defisit 5% berat badan = 5%x60x1000ml = 3000 ml Kebutuhan harian = 1500+ 20 x 40 = 2300 ml Jumlah cairan = 5300/24 jam
  • 37. KASUS DBD Perdarahan Spontan Masif (-) Syok (-) Hb,Ht (n)/ meningkat Tromb.>100-150.000 -RL 4 jam/kolf -Hb,Ht,Tromb. tiap 24 jam Hb,Ht (n)/ meningkat Tromb.<100.000 -RL 4 jam/kolf -Hb,Ht,Tromb. tiap 12 jam Hb,Ht,Tromb. (n) 24 jam stabil Hb,Ht meningkat Tromb.>100-150.000 -RL 4 jam/kolf -H,Ht,Tromb. 1 x 24 jam Klinis memburuk : TD turun , Nadi meningkat , Diuresis berkurang P rotokol DBD dengan syok Hb,Ht (n)/ meningkat Tromb.<100.000 -RL 4 jam/kolf - Hb,Ht,Tromb. 1x12 jam Pulang 24 jam Hb,Ht, Tromb.(n) Hemodinamik baik 24 jam stabil Pulang Catatan pulang : - Pasien tidak demam, hemodinamik baik - Bila keadaan pasien memburuk segera ke IGD - Kontrol poliklinik 2 x 24 jam kemudian (DPL) Penatalaksanaan Suspek DBD dewasa (tanpa syok dan perdarahan) di ruang rawat
  • 38. Penatalaksanaan Perdarahan pada DBD dewasa KASUS DBD : Perdarahan S PONTAN dan MASIF : -Epistaksis tidak terkendali -Hematemesis melena/hematoskezia -Perdarahan otak Syok (-) -DPL,hemostase KID (+) -Transfusi komponen darah : * PRC (Hb<10g * FFP * T C (Tromb.<100.000 - Heparinisasi *Hb,Ht,Tromb. tiap 4-6 jam *Ulang hemostase 24 jam kemudian KID (-) -Transfusi komponen darah : *PRC (Hb<10g% ) *FFP *T C (Tromb.<100.000) *Hb,Ht, Tromb. tiap 4-6 jam *Ulang hemostase 24 jam kemudian
  • 40.
  • 41.

Editor's Notes

  1. 6
  2. 23